Nike, Fedex Report Results… And Insmed Drops On Disappointing Results 12/18/25
CNBC's "Fast Money"
00:00
Insmed Trial Failure and Stock Drop
Jared Holes explains Insmed discontinuing a sinusitis trial, lost peak sales estimates and implications for valuation and M&A.
Play episode from 36:05
Transcript
